Gene-environment Interaction in Tobacco-related Cancers

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2008 Jun 14

PMID 18550573

Citations 38

Authors

Emanuela Taioli

Affiliations

Soon will be listed here.

Abstract

This review summarizes the carcinogenic effects of tobacco smoke and the basis for interaction between tobacco smoke and genetic factors. Examples of published papers on gene-tobacco interaction and cancer risk are presented. The assessment of gene-environment interaction in tobacco-related cancers has been more complex than originally expected for several reasons, including the multiplicity of genes involved in tobacco metabolism, the numerous substrates metabolized by the relevant genes and the interaction of smoking with other metabolic pathways. Future studies on gene-environment interaction and cancer risk should include biomarkers of smoking dose, along with markers of quantitative historical exposure to tobacco. Epigenetic studies should be added to classic genetic analyses, in order to better understand gene-environmental interaction and individual susceptibility. Other metabolic pathways in competition with tobacco genetic metabolism/repair should be incorporated in epidemiological studies to generate a more complete picture of individual cancer risk associated with environmental exposure to carcinogens.

Citing Articles

Cigarette tar accelerates atherosclerosis progression via RIPK3-dependent necroptosis mediated by endoplasmic reticulum stress in vascular smooth muscle cells.

Bai X, Wang Y, Luo X, Bao X, Weng X, Chen Y Cell Commun Signal. 2024; 22(1):41.

PMID: 38229167 PMC: 10790416. DOI: 10.1186/s12964-024-01480-6.

Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment.

Baghaei A, Behjati M, Karimian A Asian Pac J Cancer Prev. 2022; 23(11):3859-3868.

PMID: 36444599 PMC: 9930972. DOI: 10.31557/APJCP.2022.23.11.3859.

Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.

Ghosh S, Shah P, Johnson F Int J Mol Sci. 2022; 23(14).

PMID: 35887235 PMC: 9320653. DOI: 10.3390/ijms23147889.

Do Genetic Variants Modify the Effect of Smoking on Risk of Preeclampsia in Pregnancy?.

Bauer A, Avery C, Shi M, Weinberg C, Olshan A, Harmon Q Am J Perinatol. 2021; 41(1):44-52.

PMID: 34839469 PMC: 10127527. DOI: 10.1055/s-0041-1740072.

Multi-Omics Analysis of the Effects of Smoking on Human Tumors.

Wang R, Li S, Wen W, Zhang J Front Mol Biosci. 2021; 8:704910.

PMID: 34796198 PMC: 8592943. DOI: 10.3389/fmolb.2021.704910.

References

Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H . Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007; 9(2):67-73. DOI: 10.1097/gim.0b013e31803068b1. View

Kato S, Bowman E, Harrington A, Blomeke B, Shields P . Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst. 1995; 87(12):902-7. DOI: 10.1093/jnci/87.12.902. View

Khoury M, Wagener D . Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet. 1995; 56(4):835-44. PMC: 1801200. View

Badawi A, Hirvonen A, Bell D, Lang N, Kadlubar F . Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 1995; 55(22):5230-7. View

Russo A, Thiagalingam A, Pan H, Califano J, Cheng K, Ponte J . Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res. 2005; 11(7):2466-70. DOI: 10.1158/1078-0432.CCR-04-1962. View

Kadlubar F, Anderson K, Haussermann S, Lang N, Barone G, Thompson P . Comparison of DNA adduct levels associated with oxidative stress in human pancreas. Mutat Res. 1998; 405(2):125-33. DOI: 10.1016/s0027-5107(98)00129-8. View

Schoket B, Papp G, Levay K, Mrackova G, Kadlubar F, Vincze I . Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure. Mutat Res. 2001; 482(1-2):57-69. DOI: 10.1016/s0027-5107(01)00210-x. View

Rojas M, Alexandrov K, Cascorbi I, Brockmoller J, Likhachev A, Pozharisski K . High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics. 1999; 8(2):109-18. View

Ryberg D, Skaug V, Hewer A, Phillips D, Harries L, Wolf C . Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997; 18(7):1285-9. DOI: 10.1093/carcin/18.7.1285. View

10.

Chen S, Wang L, Lunn R, Tsai W, Lee P, Ahsan H . Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer. 2002; 99(1):14-21. DOI: 10.1002/ijc.10291. View

11.

Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper M . CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer. 2003; 104(5):650-7. DOI: 10.1002/ijc.10995. View

12.

Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly A . Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev. 2001; 10(12):1249-52. View

13.

Hecht S . Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002; 3(8):461-9. DOI: 10.1016/s1470-2045(02)00815-x. View

14.

Schooten F, Hirvonen A, Maas L, de Mol B, Kleinjans J, Bell D . Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 1998; 12(13):1409-17. DOI: 10.1096/fasebj.12.13.1409. View

15.

Thompson P, DeMarini D, Kadlubar F, McClure G, Brooks L, Green B . Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen. 2002; 39(2-3):134-42. DOI: 10.1002/em.10067. View

16.

Shields P, Bowman E, Harrington A, Doan V, Weston A . Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 1993; 53(15):3486-92. View

17.

Schwartz A, Prysak G, Bock C, Cote M . The molecular epidemiology of lung cancer. Carcinogenesis. 2006; 28(3):507-18. DOI: 10.1093/carcin/bgl253. View

18.

Wiencke J . DNA adduct burden and tobacco carcinogenesis. Oncogene. 2002; 21(48):7376-91. DOI: 10.1038/sj.onc.1205799. View

19.

Manuguerra M, Saletta F, Karagas M, Berwick M, Veglia F, Vineis P . XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006; 164(4):297-302. DOI: 10.1093/aje/kwj189. View

20.

Peluso M, Neri M, Margarino G, Mereu C, Munnia A, Ceppi M . Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms. Carcinogenesis. 2004; 25(12):2459-65. DOI: 10.1093/carcin/bgh259. View